IRF2 inhibits ZIKV replication by promoting FAM111A expression to enhance the host restriction effect of RFC3

Virol J. 2021 Dec 20;18(1):256. doi: 10.1186/s12985-021-01724-8.

Abstract

Background: Although interferon regulatory factor 2 (IRF2) was reported to stimulate virus replication by suppressing the type I interferon signaling pathway, because cell cycle arrest was found to promote viral replication, IRF2-regulated replication fork factor (FAM111A and RFC3) might be able to affect ZIKV replication. In this study, we aimed to investigate the function of IRF2, FAM111A and RFC3 to ZIKV replication and underlying mechanism.

Methods: siIRF2, siFAM111A, siRFC3 and pIRF2 in ZIKV-infected A549, 2FTGH and U5A cells were used to explore the mechanism of IRF2 to inhibit ZIKV replication. In addition, their expression was analyzed by RT-qPCR and western blots, respectively.

Results: In this study, we found IRF2 expression was increased in ZIKV-infected A549 cells and IRF2 inhibited ZIKV replication independent of type I IFN signaling pathway. IRF2 could activate FAM111A expression and then enhanced the host restriction effect of RFC3 to inhibit replication of ZIKV.

Conclusions: We speculated the type I interferon signaling pathway might not play a leading role in regulating ZIKV replication in IRF2-silenced cells. We found IRF2 was able to upregulate FAM111A expression and thus enhance the host restriction effect of RFC3 on ZIKV.

Keywords: FAM111A; IRF2; Jak/STAT signaling pathways; RFC3; ZIKV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Humans
  • Interferon Regulatory Factor-2
  • Receptors, Virus
  • Replication Protein C / genetics
  • Virus Replication
  • Zika Virus Infection*
  • Zika Virus* / physiology

Substances

  • FAM111A protein, human
  • IRF2 protein, human
  • Interferon Regulatory Factor-2
  • RFC3 protein, human
  • Receptors, Virus
  • Replication Protein C